Event Report - October 25th & 26th 2017 - Montreal, Quebec, Canada
Indigenous groups worldwide frequently suffer poorer mental health outcomes than non-Indigenous groups. Suicide rates in many Indigenous communities are significantly higher than in the general population, and suicide is the second leading cause of death among Indigenous youth. Indigenous communities experience numerous risk factors for suicide, including discrimination, conflict, trauma, the stresses of acculturation and dislocation, harmful use of alcohol, and barriers to accessing health care.
The meeting "Indigenous Experiences in Wellness and Suicide Prevention" held in Montreal on 25-26 October, 2017 was meant to foster an exchange of such experiences from within specific communities, in order to yield knowledge and understanding of local practices and perceptions, and to provide direction for future collaborations on the topic in the Region.
WHO-AIMS - General Information
The World Health Organization Assessment Instrument for Mental Health Systems (WHO-AIMS) is a new WHO tool for collecting essential information on the mental health system of a country or region. The goal of collecting this information is to improve mental health systems and to provide a baseline for monitoring the change.
WHAT IS WHO-AIMS?
The World Health Organization Assessment Instrument for Mental Health Systems (WHO-AIMS) is a new WHO tool for collecting essential information on the mental health system of a country or region. The goal of collecting this information is to improve mental health systems and to provide a baseline for monitoring the change. For the purpose of WHO-AIMS, a mental health system is defined as all the activities whose primary purpose is to promote, restore or maintain mental health. WHO-AIMS is primarily intended for assessing mental health systems in low and middle income countries, but is also a valuable assessment tool for high resource countries.
Note: Great care has been taken to ensure the reliability of the data presented in the WHO-AIMS country reports. Data for WHO-AIMS are collected by a team led by a focal point within the country and are, in most cases, approved by the Ministry of Health. However, since WHO is not directly responsible for the data collection, WHO cannot independently verify the accuracy of any of the data presented in these reports.
WHO-AIMS Instrument, Version 2.2
WHO-AIMS Country Reports
WHO-AIMS Subregional Reports
PAHO with the support of the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) is submitting this report, which compiles the principal available data at the country level on resources, programs and services related to the care of people with epilepsy in Latin America and the Caribbean (LAC). Information was obtained from 25 of the 33 LAC countries (76%), which responded to the assessment tool during the second semester of 2012.
A report for the Pan American Health Organization Prepared by:
Robert Kohn, MD1
Professor of Psychiatry and Human Behavior
The Warren Alpert Medical School of Brown University
? Well-designed epidemiological studies that provide information on the prevalence of mental illness and service utilization of mental health services exist in North America and in a number of countries in Latin America and the Caribbean (LAC) for adult populations, as well as for children and adolescents.
? Information on mental health resources and services are available for nearly all countries in the Americas from the World Health Organization (WHO) Atlas projects and the WHO-AIMS (World Health Organization Assessment Instrument for Mental Health Systems). These databases revealed that disparities continue to exist in mental health services and resources even among high-middle income countries, and that the mental hospital continues to be the focal point of care, despite that a lower treatment gap in schizophrenia is associated with outpatient programs and community follow-up.
? The availability of more representative data of the population of the Americas on mental health services and prevalence of mental illness has provided a better understanding of how wide the treatment gap has emerged for the Region.
? Among adults with severe and moderate affective disorders, anxiety disorders and substance use disorders, the median treatment gap is estimated to be 73.5% for the Americas, 47.2% for North America, and 77.9% for LAC. For all disorders regardless of severity the treatment gap in the Americas is 78.1%. The treatment gap in the United States for schizophrenia is 42.0%, whereas in LAC the treatment gap is 56.4%.
? The median treatment gap for the Americas for children and adolescents is 63.8% and 52.6% for severe mental disorders.
? Mental health services utilization studies of the indigenous population showed a very low use of formal mental health services among the mentally ill.
? Barriers to care continue to need to be bridged, and are one of the main obstacles to reducing the treatment gap.